Welcome Guest | Register / Login

Pharmaceuticals Market Research Reports

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this i... View more

Sort By
Title Published Price Buy Now
Ireland Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: The Irish government's four-year agreement with the pharmaceutical industry with regard to drug pricing reflects the government's continued focus on cost control measures targeting pharmaceutical expenditure. The agreed price-re...
Sep 2016 $ 1295
Iran Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: The removal of economic sanctions heralds an era of uncertainty for Iran's pharmaceutical market. Underlying issues regarding the operating environment will prevent an immediate uptick in multinational drugmaker interest; rather...
Sep 2016 $ 1295
Hungary Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: The Hungarian government's fiscal stimulus initiatives will boost the private consumption of pharmaceuticals, particularly the over the counter medicines segment. A secondary set of initiatives are aimed at increasing domestic p...
Sep 2016 $ 1295
Croatia Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Continued political instability coupled with a bleak economic outlook will continue to repress the pharmaceutical and healthcare sectors in Croatia. Necessary austerity measures will impose further barriers towards growth and re...
Sep 2016 $ 1295
Australia Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: The incumbent Liberal-National coalition's victory in Australia's federal elections will not bring about a clear policy direction for the healthcare sector. While the government has a fresh mandate to enact its policies, it is c...
Sep 2016 $ 1295
Switzerland Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Switzerland will remain amongst the wealthiest countries in the world in real GDP per capita terms, which together with an aging population and a preference for patented medicines, will keep pharmaceutical spending high. However...
Sep 2016 $ 1295
Sweden Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Declining government reimbursement for prescription medicines and the promotion of lowervalue generic medicines does not bode well for innovative drugmakers selling their products in Sweden, particularly as the government is the...
Sep 2016 $ 1295
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Economic and political challenges will continue to undermine growth within Sudan and South Sudan's pharmaceutical and healthcare markets. As such, political instability will remain a barrier to any significant investment in the ...
Sep 2016 $ 1295
Singapore Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: The delivery of healthcare in Singapore will continue to change as the country looks to deepen the integration of technology with its medical sector. This will see a shift in the flow of patients seeking medical services, their ...
Sep 2016 $ 1295
Serbia Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Serbia will remain an unattractive market for multinational drugmakers in comparison to its regional neighbours. Government cost-containment, via severe drug price cuts, and continued economic issues will dampen the country's gr...
Sep 2016 $ 1295
Puerto Rico Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: An expected increase in US government funding to strengthen Puerto Rico's healthcare system will support pharmaceutical and healthcare sector growth in the commonwealth over the next few years. While the US administration will c...
Sep 2016 $ 1295
Pakistan Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Pakistan's pharmaceutical market will remain a low priority for innovative drugmakers. Downward price pressures on pharmaceutical prices coupled with uncertainty surrounding the country's policy direction impinge on potential co...
Sep 2016 $ 1295
Oman Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: The Oman Ministry of Health's decision to postpone the latest phase of medicine price reductions highlights the opaque nature of the country's pharmaceutical sector. Over the long term, Oman's population will benefit from more a...
Sep 2016 $ 1295
Iraq Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Iraq's ailing domestic landscape will dampen investor confidence in the country's pharmaceuticals and healthcare sectors over at least the next few years if not longer. Although the government remains committed to healthcare pro...
Sep 2016 $ 1295
The Top 100 Manufacturers Of Generic Pharmaceuticals Worldwide
By Research Facts
Did you know? Zentiva, the generics business of the Sanofi Group, employs 6,000 people worldwide. Jeff Watson is President, Global Generics at Apotex, the largest Canadian-owned pharmaceutical company....
Sep 2016 $ 1145
The Top 100 Manufacturers Of Dental Implants Worldwide
By Research Facts
Did you know? Neobiotech Co. is the second biggest implant manufacturer in Korea. Institut Straumann had revenues of $U.S. 712.6 million in 2014. Sweden & Martina develops, manufactures and m...
Sep 2016 $ 1145
Sri Lanka Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Sri Lanka's pharmaceutical and healthcare markets will continue to expand over the next 10 years driven by economic development. Despite an increased level of fiscal tightening in the coming quarters, healthcare system strengthe...
Sep 2016 $ 1295
Mozambique Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Mozambique will continue to be one of the least attractive pharmaceutical and healthcare markets in the Middle East and Africa region (MEA). The escalation of political violence has directly impacted health centres in some of th...
Sep 2016 $ 1295
Morocco Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: The Moroccan government's strategy of introducing pharma-clusters in an attempt to strengthen the domestic pharmaceutical industry will see the market develop into a more attractive investment destination for multinational drugm...
Sep 2016 $ 1295
Moldova Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Moldova's pharmaceutical market presents very limited opportunities for multinational drugmakers, in comparison to its neighbours in Eastern Europe. The country's small total market size and its reliance on out-of-pocket payment...
Sep 2016 $ 1295
Lebanon Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Growth in Lebanon's pharmaceutical market will be heavily driven by the sales of high-value prescription medicines thanks to an aging population, relatively high per capita spending and rising disease burden. Furthermore, the He...
Sep 2016 $ 1295
Kuwait Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: The gradual economic recovery will support the government's plans within the healthcare sector; however, political instability poses the greatest risk to our outlook. Kuwait's political backdrop is complicated by labour and popu...
Sep 2016 $ 1295
Indonesia Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Pressure to increase premiums charged for Indonesia's universal healthcare scheme will remain as it struggles with financial stability. Financial subsidies from the government to support the programme will alleviate but not full...
Sep 2016 $ 1295
Germany Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Germany's large and expanding pharmaceutical market will continue to generate commercial opportunities for drugmakers over the forecast period. While Germany's ongoing economic rebalancing will continue to support robust domesti...
Sep 2016 $ 1295
Chile Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Chile's healthcare reform and sector investment will continue to expand the role of the state in the provision of health services and medicines. The stable political and economic outlook in Chile provides a solid foundation for ...
Sep 2016 $ 1295